U.S. Capnography Equipment Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

U.S. Capnography Equipment Market Trends and Insights

Rising Burden of COPD and Other Chronic Respiratory Conditions

The United States capnography equipment market benefits from the growing clinical burden of COPD and related respiratory disorders. In 2024, the age-adjusted COPD prevalence rate in the United States was 3.8%, with higher rates of 10.5% among adults aged 75 and older and 8.9% among those aged 65-74. Approximately 11.7 million insured individuals had a COPD diagnosis, leading to 1.8 million COPD-related acute inpatient hospitalizations. Regional disparities show higher prevalence in the South and Midwest (4.2%) compared to the West (3.1%), creating opportunities for suppliers with strong community hospital and rural system networks.^{[1]Centers for Disease Control and Prevention, National Center for Health Statistics, “Chronic Obstructive Pulmonary Disease in Adults Age 18 and Older: United States, 2023,” NCHS Data Brief No. 529, cdc.gov} The shift toward ambulatory and home settings further supports sustained demand for capnography equipment.

Higher Use of Capnography in Anesthesia and Procedural Settings

Anesthesia monitoring remains a key driver in the United States capnography equipment market, contributing 34.77% of application revenue in 2025. While operating rooms are the primary demand center, growth is expanding into recovery workflows and procedural areas requiring moderate sedation. Standards for general anesthesia and airway confirmation reinforce the importance of end-tidal carbon dioxide monitoring. Additionally, the adoption of capnography by gastroenterologists, pulmonologists, radiologists, and emergency physicians broadens its demand, favoring vendors with multispecialty sales capabilities.

Expansion of Emergency and Critical Care Monitoring

Capnography is increasingly utilized in emergency department care, procedural sedation, prehospital airway confirmation, and cardiopulmonary resuscitation. Updated guidelines from the American Board of Emergency Medicine in 2025 emphasized continuous capnography for adult deep sedation, boosting its adoption in emergency departments and EMS systems.^{[2]American Board of Emergency Medicine, “Key Advances, Practice Advance, Procedural Sedation, Adult,” American Board of Emergency Medicine, abem.org} EMS agencies, often purchasing through stable multi-year programs, provide a consistent demand channel as protocols standardize further.

Migration Toward Portable and Workflow-Integrated Monitors

Portability is a key trend shaping the United States capnography equipment market. In 2026, the FDA cleared Medtronic’s Capnostream 35 Portable Respiratory Monitor, designed for transport and ward use with multiparameter capabilities like EtCO₂, SpO₂, ECG, and noninvasive blood pressure. Masimo’s 2025 plans for 2026-2028 include moisture-wicking cannulas and enhanced OEM connectivity, highlighting a focus on portability and workflow integration. Purchasing decisions now prioritize monitors that fit seamlessly into transport, ward, ambulatory, and connected-care workflows, emphasizing integration and multiparameter functionality over standalone hardware.

Capital Cost and Recurring Consumables Burden

The United States capnography equipment market faces a commercial challenge as its model relies on upfront hardware investments and recurring disposable purchases. Vendor-specific accessories like Microstream™ filter lines and NomoLine sampling sets increase the total cost of ownership beyond the initial device purchase. This creates difficulties for rural hospitals and smaller facilities, which struggle to manage fleet upgrades and ongoing consumable costs compared to larger systems. Outside the operating room, limited direct billing pathways and reliance on the unlisted 94799 code, which requires case-by-case approval, further complicate adoption. Additionally, training and alarm management add operational burdens, slowing deployment in cost-sensitive settings.

Reimbursement and Billing Friction in Non-Acute Care Settings

Reimbursement challenges limit the expansion of the United States capnography equipment market into non-acute settings. Facilities like ambulatory endoscopy centers and pain clinics recognize the clinical value but face administrative hurdles due to unlisted billing codes, complicating capital planning. Mixed-vendor IT environments further hinder seamless integration of new devices with existing systems. Buyers increasingly prefer equipment with lower consumable costs, better interoperability, and easier deployment, driving the market toward solutions focused on workflow efficiency and cost predictability alongside clinical performance.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Product Type: Standalone Devices Dominant, Handheld Segment Reshaping Reach

Standalone capnometers accounted for 52.35% of revenue in 2025, maintaining their leadership in the United States capnography equipment market. Their dominance is driven by extensive use in operating rooms, intensive care units, and emergency departments, where waveform visibility, stable performance, and monitor compatibility are critical. Hospitals prefer these devices for their seamless integration into existing monitoring systems and minimal interoperability concerns.

Handheld capnography devices are projected to grow at a 9.65% CAGR through 2031, making them the fastest-growing segment in the United States capnography equipment market. Their growth is linked to EMS procurement, ambulatory surgery use, and the adoption of continuous respiratory monitoring in home care. As portability improves and disposable designs become more user-friendly, the focus is shifting to how quickly care protocols will adapt to these advancements.

By Component: Hardware Revenue Dominant, Consumables Compounding Fastest

Equipment contributed 45.65% of component revenue in 2025, highlighting the importance of capital device purchases in the United States capnography equipment market. Standalone and multiparameter devices dominate, forming the core monitoring footprint in hospitals and procedural settings. Software and connectivity modules are increasingly influencing purchasing decisions due to their role in integrating with broader patient monitoring systems.

Consumables are expected to grow at a 9.55% CAGR through 2031, making them the fastest-growing component category. This growth reflects the rising installed base in hospitals, emergency departments, and ambulatory sites, driving demand for nasal cannulas, sampling lines, and airway adapters. Recurring accessory demand significantly impacts margins and customer retention, complementing the role of hardware in the market.

By Technology: Sidestream Entrenched, Microstream Accelerating on Precision and Adaptability

Sidestream capnography held 59.87% of revenue in 2025, securing its leadership in the United States capnography equipment market. Its versatility with both intubated and non-intubated patients and adaptability across various clinical settings make it the preferred platform in many health systems. This broad usability ensures its continued dominance.

Microstream capnography is forecasted to grow at an 8.98% CAGR through 2031, making it the fastest-growing technology segment. Its precision, moisture handling capabilities, and ease of use for non-specialists make it ideal for diverse clinical environments. While sidestream remains dominant, microstream is rapidly gaining traction in use cases requiring higher accuracy and workflow adaptability.

By Application: Anesthesia Monitoring Anchors Revenue, Emergency Medicine Expanding Fastest

Anesthesia monitoring accounted for 34.77% of application revenue in 2025, maintaining its position as the largest application in the United States capnography equipment market. Its integral role in general anesthesia workflows and ventilatory monitoring ensures its continued demand, particularly in hospitals where quality and reliability are paramount.

Emergency medicine is projected to grow at a 10.25% CAGR through 2031, making it the fastest-growing application. The increasing use of capnography in prehospital care and moderate sedation outside traditional anesthesia settings is driving demand. Portable monitors designed for rapid deployment and rugged conditions are further supporting this growth.

By End User: Hospital Dominance Stable, Home Healthcare Emerging as Structural Growth Engine

Hospitals and clinics represented 65.47% of end-user revenue in 2025, reaffirming their role as the primary buyers in the United States capnography equipment market. Intensive care units and operating rooms drive demand, while emergency departments and medical-surgical floors contribute to refresh cycles. Established procurement cycles and infrastructure favor large-scale deployments in this segment.

Home healthcare is expected to grow at a 9.12% CAGR through 2031, emerging as the fastest-growing end-user segment. This growth is driven by unmet clinical needs and advancements in device capabilities, particularly for older COPD patients. As the market expands into home healthcare, protocol adoption and reimbursement support are becoming key challenges rather than hardware feasibility.

Geography Analysis

The United States capnography equipment market is the largest single-country demand base, supported by a robust hospital infrastructure, high patient safety standards, and diverse clinical applications requiring respiratory monitoring. The Northeast and West Coast lead in equipment density and early adoption of advanced monitoring technologies due to their concentration of academic medical centers, trauma facilities, and integrated health systems, which also influence policy and protocol development.

The South and Midwest face a higher respiratory disease burden, with COPD prevalence reaching 4.2% in 2023 compared to 3.1% in the West. States like West Virginia reported 203 COPD-related emergency department encounters per 1,000 insured patients. However, rural and critical-access hospitals in these regions often operate under tighter budgets and inconsistent reimbursement structures, leading to strong but uneven demand for capnography equipment.

Sun Belt states such as Texas, Florida, Arizona, and Georgia are emerging as growth hubs due to older populations, expanding ambulatory care, and a developed home healthcare sector. Portable monitors are gaining traction in these regions as care delivery extends beyond acute care to ambulatory, transport, and remote monitoring pathways. Home-based capnography, though nascent, aligns well with metropolitan areas equipped with remote patient monitoring infrastructure, making these states key expansion zones for the United States capnography equipment market.